Study

A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. – Cost Effective Supplements

A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/21586650


Conclusion of this study

Overall, results of the study demonstrate that children and adolescents with migraine improved over time with multidisciplinary, standardized treatment regardless of supplementation with CoQ10 or placebo. There was no difference in headache outcomes between the CoQ10 and placebo groups at day 224. Due to the improvements seen in weeks 1-4, CoQ10 may lead to earlier improvement in headache severity, but given the sample size this conclusion warrants further investigation with a larger sample.


Supplements analyzed in this study

Coenzyme Q10

Health conditions analyzed in this study

Migraine


Slightly Positive
Coenzyme Q10


Functions related to this study

Mental health


Slightly Positive
Coenzyme Q10


Body systems related to this study


Nervous System
Scroll to top